Eversept Partners, LP

SEC CIK: 0001697013
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Eversept Partners, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overview All 13F holders of REGN Full Q2 2026 holdings

Shares (Q1 2026): 0; Sold out in Q1 2026
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q2 2025

Holdings of REGN by Eversept Partners, LP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2026	0	$0	0.0%	−10,097−100.0%	Sold out	Holders
Q4 2025	10,097	$7.79M	0.4%	−6,623−39.6%	Reduced	Holders
Q3 2025	16,720	$9.40M	0.7%	+3,466+26.2%	Added	Holders
Q2 2025	13,254	$6.96M	0.7%	+13,254	New	Holders